Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome.

[1]  F. Boomsma,et al.  EFFECT OF UNNATURAL NORADRENALINE PRECURSOR ON SYMPATHETIC CONTROL AND ORTHOSTATIC HYPOTENSION IN DOPAMINE-BETA-HYDROXYLASE DEFICIENCY , 1987, The Lancet.

[2]  R. Zimmerman,et al.  Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog. , 1987, Circulation research.

[3]  T. Tulassay,et al.  Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. , 1987, Kidney international.

[4]  J. Biollaz,et al.  Pharmacokinetics of synthetic atrial natriuretic peptides in normal men , 1987, Clinical pharmacology and therapeutics.

[5]  N. Trippodo,et al.  Atrial natriuretic factor decreases whole-body capillary absorption in rats. , 1987, The American journal of physiology.

[6]  J. Fleming,et al.  Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney , 1986, Nature.

[7]  M. Dunn,et al.  A mechanism by which atrial natriuretic factor mediates its glomerular actions. , 1986, The American journal of physiology.

[8]  Andrew,et al.  Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.

[9]  M. Cantin,et al.  Distinct localization of atrial natriuretic factor and angiotensin II binding sites in the glomerulus. , 1986, The American journal of physiology.

[10]  J. H. Stein,et al.  Effect of atriopeptin II on determinants of glomerular filtration rate in the in vitro perfused dog glomerulus. , 1986, The American journal of physiology.

[11]  J. O. Davis,et al.  Renal Mechanisms for Suppression of Renin Secretion by Atrial Natriuretic Factor , 1986, Hypertension.

[12]  P. Weidmann,et al.  Blood levels and renal effects of atrial natriuretic peptide in normal man. , 1986, The Journal of clinical investigation.

[13]  G. Brabant,et al.  Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites. , 1986, Klinische Wochenschrift.

[14]  B. Brenner,et al.  Biologically active atrial peptides. , 1985, The Journal of clinical investigation.

[15]  E. Brown.  The nephrotic syndrome. , 1985, Postgraduate medical journal.

[16]  A. Richards,et al.  Effects of alpha-human atrial natriuretic peptide in essential hypertension. , 1985, Hypertension.

[17]  A. J. Man in't veld,et al.  Splint renal function after captopril in unilateral renal artery stenosis. , 1984, British medical journal.

[18]  P. Boer,et al.  Plasma and blood volumes in patients with the nephrotic syndrome. , 1984, Nephron.

[19]  B. G. Blijenberg,et al.  The Introduction of Bromocresol Purple for the Determination of Serum Albumin on SMAC and ACA, and the Standardization Procedure , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[20]  A. Ingild.  Single Radial Immunodiffusion , 1983 .

[21]  A. J. Man in 't Veld,et al.  Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. , 1983, Hypertension.

[22]  A. D. de Bold,et al.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.

[23]  H. Rennke,et al.  The Structural and Molecular Basis of Glomerular Filtration , 1978, Circulation research.

[24]  C R Robertson,et al.  Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. , 1975, Kidney international.

[25]  W. Flamenbaum,et al.  Micropuncture studies of proximal tubule albumin concentrations in normal and nephrotic rats. , 1971, The Journal of clinical investigation.